Skip to content
PubMed This is a summary of 74 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 74 referenced papers

Top Authors

Jeroen H. F. de Baaij
Radboud University Nijmegen
Detlef Böckenhauer
Great Ormond Street Hospital
Rosa Vargas‐Poussou
Assistance Publique – Hôpitaux de Paris
Martin Konrad
University of Münster
Bodo Bernhard Beck
University of Cologne
Maria Cristina D’Adamo
University of Malta
Olivier Devuyst
University of Zurich
Pascal Houillier
Centre National de la Recherche Scientifique
Stephen B. Walsh
University College London
Karl P. Schlingmann
University of Münster

Top Institutions

Ranked by publications Top 10 institutions
10

Emma Kinderziekenhuis

Amsterdam, The Netherlands

30 papers

References

References (74)
  1. 1

    Novel phenotype associated with a mutation in the KCNA1(Kv1.1) gene.

    D'Adamo MC, Gallenmüller C, Servettini I, et al.

    Frontiers in physiology 2014; (5()):525 doi:10.3389/fphys.2014.00525.

    PMID: 25642194
  2. 2

    Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations.

    Al Shibli A, Narchi H

    World journal of methodology 2015; (5(2)):55-61 doi:10.5662/wjm.v5.i2.55.

    PMID: 26140272
  3. 3

    Hypomagnesemia due to two novel TRPM6 mutations.

    Coulter M, Colvin C, Korf B, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2015; (28(11-12)):1373-8.

    PMID: 26226117
  4. 4

    QT interval prolongation associated with low magnesium in chronic alcoholics.

    Moulin SR, Mill JG, Rosa WC, et al.

    Drug and alcohol dependence 2015; (155()):195-201.

    PMID: 26249264
  5. 5

    New insights into the pathogenesis and therapeutics of episodic ataxia type 1.

    D'Adamo MC, Hasan S, Guglielmi L, et al.

    Frontiers in cellular neuroscience 2015; (9()):317 doi:10.3389/fncel.2015.00317.

    PMID: 26347608
  6. 6

    Primary renal magnesium wasting: an unusual clinical picture of exercise-induced symptoms.

    Stark CM, Nylund CM, Gorman GH, Lechner BL

    Physiological reports 2016; (4(8)).

    PMID: 27117800
  7. 7

    A case of chronic hypomagnesemia in a cancer survivor.

    Velimirovic M, Ziperstein JC, Fenves AZ

    Hospital practice (1995) 2017; (45(2)):58-64 doi:10.1080/21548331.2017.1286924.

    PMID: 28114816
  8. 8

    Lessons learned from a multidisciplinary renal genetics clinic.

    Alkanderi S, Yates LM, Johnson SA, Sayer JA

    QJM : monthly journal of the Association of Physicians 2017; (110(7)):453-457 doi:10.1093/qjmed/hcx030.

    PMID: 28177086
  9. 9

    Seizures Related to Hypomagnesemia: A Case Series and Review of the Literature.

    Chen BB, Prasad C, Kobrzynski M, et al.

    Child neurology open 2016; (3()):2329048X16674834 doi:10.1177/2329048X16674834.

    PMID: 28503619
  10. 10

    [Expert consensus for the diagnosis and treatment of patients with Gitelman syndrome].

    Zhonghua nei ke za zhi 2017; (56(9)):712-716 doi:10.3760/cma.j.issn.0578-1426.2017.09.021.

    PMID: 28870047
  11. 11

    Intestinal Absorption and Factors Influencing Bioavailability of Magnesium-An Update.

    Schuchardt JP, Hahn A

    Current nutrition and food science 2017; (13(4)):260-278 doi:10.2174/1573401313666170427162740.

    PMID: 29123461
  12. 12

    Pharmacokinetics of Magnesium Bolus Therapy in Cardiothoracic Surgery.

    Biesenbach P, Mårtensson J, Lucchetta L, et al.

    Journal of cardiothoracic and vascular anesthesia 2018; (32(3)):1289-1294 doi:10.1053/j.jvca.2017.08.049.

    PMID: 29169799
  13. 13

    Simultaneous sequencing of 37 genes identified causative mutations in the majority of children with renal tubulopathies.

    Ashton EJ, Legrand A, Benoit V, et al.

    Kidney international 2018; (93(4)):961-967 doi:10.1016/j.kint.2017.10.016.

    PMID: 29398133
  14. 14

    De novo HNF1 homeobox B mutation as a cause for chronic, treatment-resistant hypomagnesaemia.

    Stiles CE, Thuraisingham R, Bockenhauer D, et al.

    Endocrinology, diabetes & metabolism case reports 2018; (2018()).

    PMID: 29576871
  15. 15

    A de novo KCNA1 Mutation in a Patient with Tetany and Hypomagnesemia.

    van der Wijst J, Konrad M, Verkaart SAJ, et al.

    Nephron 2018; (139(4)):359-366 doi:10.1159/000488954.

    PMID: 29791908
  16. 16

    Hypomagnesemia and hypermagnesemia.

    Van Laecke S

    Acta clinica Belgica 2019; (74(1)):41-47 doi:10.1080/17843286.2018.1516173.

    PMID: 30220246
  17. 17

    [Management of Gitelman syndrome during pregnancy reporting 12 cases].

    Elbouajaji K, Blanchier D, Pourrat O, Sarreau M

    Nephrologie & therapeutique 2018; (14(7)):536-543 doi:10.1016/j.nephro.2018.06.003.

    PMID: 30309814
  18. 18

    Electrolytes disturbances after kidney transplantation.

    De Waele L, Van Gaal PJ, Abramowicz D

    Acta clinica Belgica 2019; (74(1)):48-52 doi:10.1080/17843286.2018.1549193.

    PMID: 30482110
  19. 19

    Intravenous infusion of magnesium sulfate is not associated with cardiovascular, liver, kidney, and metabolic toxicity in adults.

    Karhu E, Atlas SE, Gao J, et al.

    Journal of clinical and translational research 2018; (4(1)):47-55.

    PMID: 30873494
  20. 20

    The challenges of diagnosis and management of Gitelman syndrome.

    Urwin S, Willows J, Sayer JA

    Clinical endocrinology 2020; (92(1)):3-10 doi:10.1111/cen.14104.

    PMID: 31578736
  21. 21

    Transition of patients with mucopolysaccharidosis from paediatric to adult care.

    Lampe C, McNelly B, Gevorkian AK, et al.

    Molecular genetics and metabolism reports 2019; (21()):100508 doi:10.1016/j.ymgmr.2019.100508.

    PMID: 31687335
  22. 22

    Treatment Difficulties in Hypomagnesemia Secondary to the Transient Receptor Potential Melastatin 6 Gene: A Case Report with Novel Mutation

    Yücel H, Genç Sel Ç, Kasapkara ÇS, et al.

    Journal of clinical research in pediatric endocrinology 2021; (13(1)):114-118 doi:10.4274/jcrpe.galenos.2020.2020.0004.

    PMID: 32302086
  23. 23

    Clinical Spectrum of KCNA1 Mutations: New Insights into Episodic Ataxia and Epilepsy Comorbidity.

    Paulhus K, Ammerman L, Glasscock E

    International journal of molecular sciences 2020; (21(8)) doi:10.3390/ijms21082802.

    PMID: 32316562
  24. 24

    Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches.

    D'Adamo MC, Liantonio A, Rolland JF, et al.

    International journal of molecular sciences 2020; (21(8)) doi:10.3390/ijms21082935.

    PMID: 32331416
  25. 25

    Hypomagnesemia is underestimated in children with HNF1B mutations.

    Kołbuc M, Leßmeier L, Salamon-Słowińska D, et al.

    Pediatric nephrology (Berlin, Germany) 2020; (35(10)):1877-1886 doi:10.1007/s00467-020-04576-6.

    PMID: 32388583
  26. 26

    Neuromuscular tetanic hyperexcitability syndrome associated to a heterozygous Kv1.1 N255D mutation with normal serum magnesium levels.

    Bianchi F, Simoncini C, Brugnoni R, et al.

    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2020; (39(1)):36-39 doi:10.36185/2532-1900-007.

    PMID: 32607479
  27. 27

    Two novel KCNA1 variants identified in two unrelated Chinese families affected by episodic ataxia type 1 and neurodevelopmental disorders.

    Yuan H, Yuan H, Wang Q, et al.

    Molecular genetics & genomic medicine 2020; (8(10)):e1434 doi:10.1002/mgg3.1434.

    PMID: 32705822
  28. 28

    Musculoskeletal Features without Ataxia Associated with a Novel de novo Mutation in KCNA1 Impairing the Voltage Sensitivity of Kv1.1 Channel.

    Imbrici P, Accogli A, Blunck R, et al.

    Biomedicines 2021; (9(1)) doi:10.3390/biomedicines9010075.

    PMID: 33466780
  29. 29

    The ECG Characteristics of Patients With Isolated Hypomagnesemia.

    Yang Y, Chen C, Duan P, et al.

    Frontiers in physiology 2020; (11()):617374 doi:10.3389/fphys.2020.617374.

    PMID: 33584338
  30. 30

    Challenges in Transition From Childhood to Adulthood Care in Rare Metabolic Diseases: Results From the First Multi-Center European Survey.

    Stepien KM, Kieć-Wilk B, Lampe C, et al.

    Frontiers in medicine 2021; (8()):652358 doi:10.3389/fmed.2021.652358.

    PMID: 33738294
  31. 31

    Distal renal tubular acidosis: ERKNet/ESPN clinical practice points.

    Trepiccione F, Walsh SB, Ariceta G, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2021; (36(9)):1585-1596 doi:10.1093/ndt/gfab171.

    PMID: 33914889
  32. 32

    Molecular Mechanisms of Renal Magnesium Reabsorption.

    Ellison DH, Maeoka Y, McCormick JA

    Journal of the American Society of Nephrology : JASN 2021; (32(9)):2125-2136 doi:10.1681/ASN.2021010042.

    PMID: 34045316
  33. 33

    The Molecular Basis of Calcium and Phosphorus Inherited Metabolic Disorders.

    Papadopoulou A, Bountouvi E, Karachaliou FE

    Genes 2021; (12(5)) doi:10.3390/genes12050734.

    PMID: 34068220
  34. 34

    Ultra-rare renal diseases diagnosed with whole-exome sequencing: Utility in diagnosis and management.

    Jung J, Lee JH, Park YS, et al.

    BMC medical genomics 2021; (14(1)):177 doi:10.1186/s12920-021-01026-6.

    PMID: 34217267
  35. 35

    Spectrum of neuro-genetic disorders in the United Arab Emirates national population.

    Saleh S, Beyyumi E, Al Kaabi A, et al.

    Clinical genetics 2021; (100(5)):573-600 doi:10.1111/cge.14044.

    PMID: 34374989
  36. 36

    Diagnostic Dilemma in an Adolescent Girl with an Eating Disorder, Intellectual Disability, and Hypomagnesemia.

    Bamhraz AA, Franken GAC, de Baaij JHF, et al.

    Nephron 2021; (145(6)):717-720 doi:10.1159/000518173.

    PMID: 34515155
  37. 37

    Therapeutic Potential of Sodium Channel Blockers as a Targeted Therapy Approach in KCNA1-Associated Episodic Ataxia and a Comprehensive Review of the Literature.

    Lauxmann S, Sonnenberg L, Koch NA, et al.

    Frontiers in neurology 2021; (12()):703970 doi:10.3389/fneur.2021.703970.

    PMID: 34566847
  38. 38

    mTOR-Activating Mutations in RRAGD Are Causative for Kidney Tubulopathy and Cardiomyopathy.

    Schlingmann KP, Jouret F, Shen K, et al.

    Journal of the American Society of Nephrology : JASN 2021; (32(11)):2885-2899 doi:10.1681/ASN.2021030333.

    PMID: 34607910
  39. 39

    Clinical and genetic approach to renal hypomagnesemia.

    Tseng MH, Konrad M, Ding JJ, Lin SH

    Biomedical journal 2022; (45(1)):74-87 doi:10.1016/j.bj.2021.11.002.

    PMID: 34767995
  40. 40

    SUDEP risk and autonomic dysfunction in genetic epilepsies.

    Sahly AN, Shevell M, Sadleir LG, Myers KA

    Autonomic neuroscience : basic & clinical 2022; (237()):102907 doi:10.1016/j.autneu.2021.102907.

    PMID: 34773737
  41. 41

    Distinct epilepsy phenotypes and response to drugs in KCNA1 gain- and loss-of function variants.

    Miceli F, Guerrini R, Nappi M, et al.

    Epilepsia 2022; (63(1)):e7-e14 doi:10.1111/epi.17118.

    PMID: 34778950
  42. 42

    Rare Disease Registries Are Key to Evidence-Based Personalized Medicine: Highlighting the European Experience.

    Kölker S, Gleich F, Mütze U, Opladen T

    Frontiers in endocrinology 2022; (13()):832063 doi:10.3389/fendo.2022.832063.

    PMID: 35317224
  43. 43

    Episodic Ataxia Type 1: Natural History and Effect on Quality of Life.

    Graves TD, Griggs RC, Bundy BN, et al.

    Cerebellum (London, England) 2023; (22(4)):578-586 doi:10.1007/s12311-021-01360-6.

    PMID: 35655106
  44. 44

    Hypomagnesemia, Hypocalcemia, and Tubulointerstitial Nephropathy Caused by Claudin-16 Autoantibodies.

    Figueres L, Bruneau S, Prot-Bertoye C, et al.

    Journal of the American Society of Nephrology : JASN 2022; (33(7)):1402-1410 doi:10.1681/ASN.2022010060.

    PMID: 35728884
  45. 45

    Outcome of primary tubular tubulopathies diagnosed in pediatric age.

    Gómez CJB, Gil-Peña H, Álvarez FAO, Rodríguez FS

    Nefrologia 2021; (41(2)):182-190 doi:10.1016/j.nefroe.2020.07.001.

    PMID: 36165379
  46. 46

    Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope.

    Groothoff JW, Metry E, Deesker L, et al.

    Nature reviews. Nephrology 2023; (19(3)):194-211 doi:10.1038/s41581-022-00661-1.

    PMID: 36604599
  47. 47

    Fibroblast growth factor 23 is independently associated with renal magnesium handling in patients with chronic kidney disease.

    Grigore TV, Zuidscherwoude M, Witasp A, et al.

    Frontiers in endocrinology 2022; (13()):1046392 doi:10.3389/fendo.2022.1046392.

    PMID: 36699036
  48. 48

    Acquired Disorders of Hypomagnesemia.

    Rosner MH, Ha N, Palmer BF, Perazella MA

    Mayo Clinic proceedings 2023; (98(4)):581-596 doi:10.1016/j.mayocp.2022.12.002.

    PMID: 36872194
  49. 49

    Movement Disorders and Other Neurologic Impairment Associated With Hypomagnesemia: A Systematic Review.

    Ray S, Park KW

    Neurology. Clinical practice 2023; (13(6)):e200202 doi:10.1212/CPJ.0000000000200202.

    PMID: 37795503
  50. 50

    Oral magnesium supplementation does not affect insulin sensitivity in people with insulin-treated type 2 diabetes and a low serum magnesium: a randomised controlled trial.

    Drenthen LCA, de Baaij JHF, Rodwell L, et al.

    Diabetologia 2024; (67(1)):52-61 doi:10.1007/s00125-023-06029-9.

    PMID: 37922013
  51. 51

    Long-Term Indomethacin Treatment in a Chinese Child with Gitelman Syndrome: Case Report and Literature Review on its Efficacy and Tolerance.

    Peng X, Chen C, Tu J, et al.

    The American journal of case reports 2023; (24()):e941627 doi:10.12659/AJCR.941627.

    PMID: 38069462
  52. 52

    Identification of a Novel Homozygous Missense Mutation in the CLDN16 Gene to Decipher the Ambiguous Clinical Presentation Associated with Autosomal Dominant Hypocalcaemia and Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis in an Indian Family.

    Thapa R, Roy A, Nayek K, Basu A

    Calcified tissue international 2024; (114(2)):110-118 doi:10.1007/s00223-023-01142-8.

    PMID: 38078932
  53. 53

    Diagnostic delay in monogenic disease: A scoping review.

    Tinker RJ, Fisher M, Gimeno AF, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2024; (26(4)):101074 doi:10.1016/j.gim.2024.101074.

    PMID: 38243783
  54. 54

    Utility of fractional excretion of magnesium in diagnosing renal magnesium wasting in pediatric nephrology practice.

    Awazu M, Matsumura K

    Clinical biochemistry 2024; (131-132()):110807 doi:10.1016/j.clinbiochem.2024.110807.

    PMID: 39059606
  55. 55

    Proton pump inhibitor-induced hypomagnesemia, a rare cause of reversible delirium: A case report with literature review.

    Zhao W, Zhang J, Jia H, et al.

    Medicine 2024; (103(40)):e39729 doi:10.1097/MD.0000000000039729.

    PMID: 39465769
  56. 56

    Dent disease: clinical practice recommendations.

    Bökenkamp A, Ariceta G, Böckenhauer D, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2025; (40(5)):852-864 doi:10.1093/ndt/gfaf003.

    PMID: 39794284
  57. 57

    Diagnosis and Treatment of Hypophosphatasia.

    Seefried L, Genest F, Hofmann C, et al.

    Calcified tissue international 2025; (116(1)):46 doi:10.1007/s00223-025-01356-y.

    PMID: 40047955
  58. 58

    Reversible Bilateral Lower Extremity Weakness Secondary to Severe Hypomagnesemia Following Acute Diarrheal Illness.

    Molina M, Mejia Landron R, Kaddour-Hocine F, et al.

    Cureus 2025; (17(3)):e81077 doi:10.7759/cureus.81077.

    PMID: 40271332
  59. 59

    Dysmagnesemia in critically ill diarrheal patients in Bangladesh.

    Alam A, Mamun GMS, Sarmin M, et al.

    PloS one 2025; (20(5)):e0323467 doi:10.1371/journal.pone.0323467.

    PMID: 40388464
  60. 60

    How to Suspect and Approach Patients With Genetic Tubular Disease.

    Karet Frankl FE

    Seminars in nephrology 2025; (45(4)):151654 doi:10.1016/j.semnephrol.2025.151654.

    PMID: 40681419
  61. 61

    Novel CNNM2 variant causing hypomagnesemia and early-onset calcium pyrophosphate deposition disease: A case report.

    Robert C, Perrot L, Zelus A, et al.

    Joint bone spine 2026; (93(1)):105982 doi:10.1016/j.jbspin.2025.105982.

    PMID: 41022172
  62. 62

    Profound Hypomagnesemia Due to Proton Pump Inhibitor Use-Associated Wernicke's Encephalopathy: A Case Report on Excitotoxicity.

    Delforge B, Volon B, Laurent Y, Steinier C

    Cureus 2025; (17(10)):e94687 doi:10.7759/cureus.94687.

    PMID: 41246742
  63. 63

    Clinical Characteristics, Symptoms, and Long-Term Outcomes in Gitelman Syndrome.

    Wieërs MLAJ, Allard L, D'Ambrosio V, et al.

    Kidney international reports 2025; (10(11)):3967-3983 doi:10.1016/j.ekir.2025.09.006.

    PMID: 41278357
  64. 64

    Vonoprazan-associated hypomagnesemia presenting to the emergency department with altered mental status and a suspected seizure.

    Okamoto N, Onishi S, Manabe T, et al.

    The American journal of emergency medicine 2026; (101()):131-134 doi:10.1016/j.ajem.2025.12.034.

    PMID: 41512442
  65. 65

    Multiple dyselectrolytemia in a patient with alcohol use disorder (AUD).

    Abe E, Kawai Y, Sato M, et al.

    CEN case reports 2026; (15(2)):53 doi:10.1007/s13730-025-01054-6.

    PMID: 41692905
  66. 66

    Clinical characteristics and genetic analyses of Korean children with Dent disease.

    Yang EM, Ahn YH, Kim JH, et al.

    Pediatric nephrology (Berlin, Germany) 2026; (41(9)):3081-3091 doi:10.1007/s00467-026-07291-w.

    PMID: 42000952
  67. 67

    Familial hypomagnesemia with hypercalciuria and nephrocalcinosis treated with living-donor kidney transplantation: case report.

    Kaba A, Kaku K, Shingaki K, et al.

    CEN case reports 2026; (15(3)).

    PMID: 42095997
  68. 68

    Molecular Basis of Rare Inherited Tubulopathies of the Kidney: A Primer for Clinicians.

    Vecino-Pérez M, García-Murias M, Carrera N, et al.

    International journal of molecular sciences 2026; (27(9)) doi:10.3390/ijms27093940.

    PMID: 42123522
  69. 69

    Gitelman Syndrome in a Child Presenting With Polyuria and Polydipsia: Diagnostic Challenges in a Resource-Limited Setting.

    Ernest E, Simbila D

    Case reports in nephrology 2026; (2026()):8879176 doi:10.1155/crin/8879176.

    PMID: 42254956
  70. 70

    Atrial Flutter-Triggered Ventricular Tachycardia Storm in Gitelman Syndrome: A Case Report.

    Elganainy M, Hammami AS, Peltz J, Oriaifo OF

    Cureus 2026; (18(6)):e110146 doi:10.7759/cureus.110146.

    PMID: 42403806
  71. 71

    Home Parenteral Support in Severe Gitelman Syndrome: A Case Report.

    Martin G, Fahal I, Mehta S

    Clinical case reports 2026; (14(7)):e73210 doi:10.1002/ccr3.73210.

    PMID: 42487655
  72. 72

    Renal TRPM6 but not Kv1.1 is required for magnesium homeostasis in mice.

    Thaitongsuk P, Girardi ACC, Morrow A, et al.

    American journal of physiology. Renal physiology 2026; (331(3)):F398-F410 doi:10.1152/ajprenal.00137.2026.

    PMID: 42572410
  73. 73

    Familial hypomagnesemia with secondary hypocalcemia: a novel TRPM6 mutation associated with treatment-resistant migraine in a North African family.

    Paola PM, Gianni C, Emanuele M, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(10)).

    PMID: 42830330
  74. 74

    Familial Hypomagnesemia With Hypercalciuria and Nephrocalcinosis: A Case Report of Compound Heterozygous Variants in the CLDN16 Gene Inherited From Symptomatic Heterozygous Carriers.

    Ceol M, Sgrò E, Anglani F, et al.

    Case reports in nephrology and dialysis 2026; (16(1)):162-170 doi:10.1159/cnd/abxag006.

    PMID: 42960388